Effect of the displacement rate and inclination angle in steel fiber pullout tests

This paper summarizes the results obtained in an experimental campaign on the effect of the displacement pullout rate and the inclination angle of the steel fiber pullout tests. For that purpose, specimens were obtained from a self-compacting concrete with a compressive strength of 86 MPa. In the experimental program, hooked-end steel fibers of 0.75 mm diameter and 60 mm length were used. Tests were executed with both hooked-end fibers, and smooth fibers obtained from the former by cutting the hooked end. For both type of fibers, their embedment length into concrete was 20 mm, and the influence of fiber inclination angle toward the load direction was investigated by adopting values of 0∘, 30∘ and 60∘. The tests were performed at displacement rates of 0.01, 0.1 and 1 mm/s. The results have shown that the peak pullout load increased with the inclination angle, in particular for the smooth series. Furthermore, higher displacement rates led to a higher energy absorption capacity for the pullout of the smooth fibers, while the energy absorption remained almost stable for hooked-end fibers.project BIA2015-68678-C2-1-R. M. Tarifa appreciates the financial support from the Department of Applied Mechanics and Project Engineering, UCLM (2018), and from the Programa propio de I+D+i de la Universidad Politécnica de Madrid para realizar estancias de investigación internacional igual o superior a un mes (2019), to do two stays at the University of Minho, Guimarães, Portugal. E. Poveda acknowledges the funding from the International Campus of Excellence CYTEMA and the University of Castilla-La Mancha, throughout Ayudas para estancias en universidades y centros de investigación en el extranjero en 2019 en el ámbito del plan propio de investigación susceptibles de cofinanciación por el Fondo Europeo de Desarrollo Regional (FEDER), Programa 010100021 to fund her stays in the University of Minho during 2018 and 2019, respectively. The authors thank the support of the Department of Civil Engineering and the Laboratory of the Structural Division (LEST), University of Minh

Tensile crack widths of strain hardening cement-based composites

Please help us populate SUNScholar with the post print version of this article. It can be e-mailed to: [email protected] Ingenieurswes

The comparison between the cracking behaviour of bending and tension for Strain Hardening Cement-based Composites (SHCC)

IngenieursweseSiviele IngenieurswesePlease help us populate SUNScholar with the post print version of this article. It can be e-mailed to: [email protected]

Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone

BACKGROUND: The safe and appropriate use of long-acting beta-agonists (LABAs) for the treatment of asthma has been widely debated. In two large clinical trials, investigators found a potential risk of serious asthma-related events associated with LABAs. This study was designed to evaluate the risk of administering the LABA salmeterol in combination with an inhaled glucocorticoid, fluticasone propionate. METHODS: In this multicenter, randomized, double-blind trial, adolescent and adult patients (age, ≥12 years) with persistent asthma were assigned to receive either fluticasone with salmeterol or fluticasone alone for 26 weeks. All the patients had a history of a severe asthma exacerbation in the year before randomization but not during the previous month. Patients were excluded from the trial if they had a history of life-threatening or unstable asthma. The primary safety end point was the first serious asthma-related event (death, endotracheal intubation, or hospitalization). Noninferiority of fluticasone-salmeterol to fluticasone alone was defined as an upper boundary of the 95% confidence interval for the risk of the primary safety end point of less than 2.0. The efficacy end point was the first severe asthma exacerbation. RESULTS: Of 11,679 patients who were enrolled, 67 had 74 serious asthma-related events, with 36 events in 34 patients in the fluticasone-salmeterol group and 38 events in 33 patients in the fluticasone-only group. The hazard ratio for a serious asthma-related event in the fluticasone-salmeterol group was 1.03 (95% confidence interval [CI], 0.64 to 1.66), and noninferiority was achieved (P=0.003). There were no asthma-related deaths; 2 patients in the fluticasone-only group underwent asthma-related intubation. The risk of a severe asthma exacerbation was 21% lower in the fluticasone-salmeterol group than in the fluticasone-only group (hazard ratio, 0.79; 95% CI, 0.70 to 0.89), with at least one severe asthma exacerbation occurring in 480 of 5834 patients (8%) in the fluticasone-salmeterol group, as compared with 597 of 5845 patients (10%) in the fluticasone-only group (P<0.001). CONCLUSIONS: Patients who received salmeterol in a fixed-dose combination with fluticasone did not have a significantly higher risk of serious asthma-related events than did those who received fluticasone alone. Patients receiving fluticasone-salmeterol had fewer severe asthma exacerbations than did those in the fluticasone-only group